Henlius and Dr. Reddy's Forge Licensing Agreement for HLX15 Expansion Across Europe and the U.S. Henlius partners with Dr. Reddy's Laboratories to expand HLX15, a biosimilar to daratumumab, in Europe and the U.S., enhancing treatment options.

Henlius and Dr. Reddy's Forge Licensing Agreement for HLX15 Expansion Across Europe and the U.S. #China #Shanghai #Henlius #Dr._Reddy's #HLX15

Henlius and Dr. Reddy's Sign Licensing Agreement for HLX15 Expansion in Europe and US Henlius partners with Dr. Reddy's to expand the investigational biosimilar HLX15 in Europe and the US, aiming for better patient treatment options.

Henlius and Dr. Reddy's Sign Licensing Agreement for HLX15 Expansion in Europe and US #China #Shanghai #Henlius #Dr._Reddy's #HLX15

Henlius and Dr. Reddy's Form Strategic Alliance for HLX15 Biosimilar in Europe and U.S. Shanghai Henlius Biotech has announced a licensing agreement with Dr. Reddy's Laboratories for the HLX15 biosimilar, facilitating expansion in Europe and the U.S.

Henlius and Dr. Reddy's Form Strategic Alliance for HLX15 Biosimilar in Europe and U.S. #China #Shanghai #Henlius #Dr._Reddy's #HLX15